Envestnet Asset Management’s Rocket Pharmaceuticals RCKT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-34,286
| Closed | -$229K | – | 4534 |
|
|
2025
Q1 | $229K | Buy |
34,286
+1,864
| +6% | +$12.4K | ﹤0.01% | 4077 |
|
|
2024
Q4 | $408K | Buy |
32,422
+1,280
| +4% | +$16.1K | ﹤0.01% | 3703 |
|
|
2024
Q3 | $575K | Buy |
31,142
+1,351
| +5% | +$25K | ﹤0.01% | 3469 |
|
|
2024
Q2 | $641K | Buy |
29,791
+1,222
| +4% | +$26.3K | ﹤0.01% | 3313 |
|
|
2024
Q1 | $770K | Sell |
28,569
-2,182
| -7% | -$58.8K | ﹤0.01% | 3193 |
|
|
2023
Q4 | $922K | Buy |
30,751
+5,992
| +24% | +$180K | ﹤0.01% | 2990 |
|
|
2023
Q3 | $507K | Buy |
24,759
+7,315
| +42% | +$150K | ﹤0.01% | 3247 |
|
|
2023
Q2 | $347K | Buy |
17,444
+3,356
| +24% | +$66.7K | ﹤0.01% | 3414 |
|
|
2023
Q1 | $241K | Buy |
14,088
+1,048
| +8% | +$18K | ﹤0.01% | 3558 |
|
|
2022
Q4 | $255K | Buy |
+13,040
| New | +$255K | ﹤0.01% | 3536 |
|